These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17551485)

  • 21. Childhood growth hormone deficiency (GHD) and idiopathic short stature (ISS): how far can a consensus go?
    J Pediatr Endocrinol Metab; 2004 Feb; 17 Suppl 2():251-6. PubMed ID: 15116947
    [No Abstract]   [Full Text] [Related]  

  • 22. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
    Darendeliler F; Karagiannis G; Wilton P
    Horm Res; 2007; 68 Suppl 5():41-7. PubMed ID: 18174706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone treatment in patients with hypochondroplasia.
    Regelmann MO; Rapaport R
    Horm Res Paediatr; 2014; 82(6):353-4. PubMed ID: 25531227
    [No Abstract]   [Full Text] [Related]  

  • 24. Etiology and patterns of presentation of short stature in Eastern Cape of South Africa.
    Ekpebegh C
    Minerva Endocrinol; 2018 Jun; 43(2):225-227. PubMed ID: 29761686
    [No Abstract]   [Full Text] [Related]  

  • 25. Determinants of short stature and the response to growth hormone therapy.
    Dunger DB
    Horm Res; 2009 Apr; 71 Suppl 2():2-4. PubMed ID: 19407490
    [No Abstract]   [Full Text] [Related]  

  • 26. hGH for short stature: ethical issues raised by expanded access.
    Allen DB; Fost N
    J Pediatr; 2004 May; 144(5):648-52. PubMed ID: 15127004
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis of growth hormone deficiency by using the arginine provocative test: is it possible to shorten testing time without altering validity?
    Galluzzi F; Quaranta MR; Salti R; Stagi S; Nanni L; Seminara S
    Horm Res; 2009; 72(3):142-5. PubMed ID: 19729944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for pharmacotherapy, nutritional management, and weaning parenteral nutrition in adult patients with short bowel syndrome: introduction.
    Steiger E
    J Clin Gastroenterol; 2006; 40 Suppl 2():S73-4. PubMed ID: 16770165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic short stature: management and growth hormone treatment.
    Wit JM; Reiter EO; Ross JL; Saenger PH; Savage MO; Rogol AD; Cohen P
    Growth Horm IGF Res; 2008 Apr; 18(2):111-35. PubMed ID: 18178498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ; Rogol AD
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of concordance in growth hormone therapy.
    Kapoor RR; Burke SA; Sparrow SE; Hughes IA; Dunger DB; Ong KK; Acerini CL
    Arch Dis Child; 2008 Feb; 93(2):147-8. PubMed ID: 17768149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulant medication use and response to growth hormone therapy: an NCGS database analysis.
    Frindik JP; Morales A; Fowlkes J; Kemp S; Thrailkill K; Lippe B; Dana K
    Horm Res; 2009; 72(3):160-6. PubMed ID: 19729947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O; Lindberg A;
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age.
    Lagrou K; Froidecoeur C; Thomas M; Massa G; Beckers D; Craen M; de Beaufort C; Rooman R; François I; Heinrichs C; Lebrethon MC; Thiry-Counson G; Maes M; De Schepper J
    Horm Res; 2008; 69(6):334-42. PubMed ID: 18504392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature - part 2: available results and future directions.
    Bullinger M; Kołtowska-Häggström M; Sandberg D; Chaplin J; Wollmann H; Noeker M; Brütt AL
    Horm Res; 2009; 72(2):74-81. PubMed ID: 19690424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA; Arnhold IJ
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IGF-I response to growth hormone is related to body mass index in short children with normal weight.
    Roman R; Iniguez G; Lammoglia JJ; Avila A; Salazar T; Cassorla F
    Horm Res; 2009; 72(1):10-4. PubMed ID: 19571554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 40. 50 Years Ago in TheJournalofPediatrics: Treatment of Nonorganic Short Stature: The Quest Continues.
    Dabas A; Gupta P
    J Pediatr; 2021 Dec; 239():58. PubMed ID: 34794644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.